Treatment of Multiple Sclerosis With Copaxone and Albuterol

This study is ongoing, but not recruiting participants.
Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Autoimmune Diseases
			Multiple Sclerosis
2		Additional conditions recognized in this trial
			Sclerosis
3		More general conditions related to this trial
			Autoimmune Diseases of the Nervous System
			Demyelinating Autoimmune Diseases, CNS
			Demyelinating Diseases
			Immune System Diseases
			Nervous System Diseases
			Pathologic Processes
4		Interventions listed in this trial
			Glatiramer acetate
			Albuterol
5		Additional drug interventions recognized in this trial
			Copolymer 1
6		More general drug interventions related to this trial
			Adjuvants, Immunologic
			Adrenergic Agents
			Adrenergic Agonists
			Adrenergic beta-Agonists
			Anti-Asthmatic Agents
			Autonomic Agents
			Bronchodilator Agents
			Immunologic Factors
			Immunosuppressive Agents
			Molecular Mechanisms of Pharmacological Action
			Neurotransmitter Agents
			Peripheral Nervous System Agents
			Pharmacologic Actions
			Physiological Effects of Drugs
			Reproductive Control Agents
			Respiratory System Agents
			Therapeutic Uses
			Tocolytic Agents
7		Sponsors listed in this trial
			National Institute of Allergy and Infectious Diseases (NIAID)
			Autoimmune Centers of Excellence